24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)

Clinical trial NCT05634746 · COMPLETED

Trial details

NCT number: NCT05634746
Sponsor: Ellodi Pharmaceuticals, LP
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Eosinophilic Esophagitis

Start date: 2022-12-29
Primary completion: 2024-08-12
Enrollment: 218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.